Early research (Phase 1)Ended earlyNCT04618263
What this trial is testing
Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers
Who this might be right for
Major Depressive DisorderExcessive Sleepiness
Syndeio Biosciences, Inc 18